Jerome Place
Overview
Explore the profile of Jerome Place including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
952
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Renard E, Joubert M, Villard O, Dreves B, Reznik Y, Farret A, et al.
Diabetes Care
. 2023 Sep;
46(12):2180-2187.
PMID: 37729080
Objective: Assess the safety and efficacy of automated insulin delivery (AID) in adults with type 1 diabetes (T1D) at high risk for hypoglycemia. Research Design And Methods: Participants were 72...
2.
Coutant R, Bismuth E, Bonnemaison E, Dalla-Vale F, Morinais P, Perrard M, et al.
Diabetes Technol Ther
. 2023 Mar;
25(6):395-403.
PMID: 36927054
It is unclear whether hybrid closed-loop (HCL) therapy attenuates the metabolic impact of missed or suboptimal meal insulin bolus compared with sensor-augmented pump (SAP) therapy in children with type 1...
3.
Renard E, Tubiana-Rufi N, Bonnemaison E, Coutant R, Dalla-Vale F, Bismuth E, et al.
Diabetes Obes Metab
. 2021 Nov;
24(3):511-521.
PMID: 34816597
Aim: To assess the safety and efficacy of hybrid closed-loop (HCL) insulin delivery 24/7 versus only evening and night (E/N), and on extended 24/7 use, in free-living children with type...
4.
He J, Renard E, Lord P, Cohen D, Cem-Duranty E, Place J, et al.
J Control Release
. 2021 Jun;
336:1-15.
PMID: 34118339
Continuous intraperitoneal insulin infusion, from an implanted insulin pump connected to a catheter that delivers insulin directly to the peritoneal cavity has many clinical advantages for patients with Type 1...
5.
Renard E, Tubiana-Rufi N, Bonnemaison-Gilbert E, Coutant R, Dalla-Vale F, Farret A, et al.
Diabetes Obes Metab
. 2018 Jul;
21(1):183-187.
PMID: 30047223
This randomized control trial investigated glucose control with closed-loop (CL) versus threshold-low-glucose-suspend (TLGS) insulin pump delivery in pre-pubertal children with type 1 diabetes in supervised hotel conditions. The patients [n ...
6.
Dassau E, Renard E, Place J, Farret A, Pelletier M, Lee J, et al.
Diabetes Obes Metab
. 2017 May;
19(12):1698-1705.
PMID: 28474383
Aims: To compare intraperitoneal (IP) to subcutaneous (SC) insulin delivery in an artificial pancreas (AP). Research Design And Methods: Ten adults with type 1 diabetes participated in a non-randomized, non-blinded...
7.
Marchand L, Luigi P, Place J, Dalla-Vale F, Farret A, Renard E
Diabetes Care
. 2017 Apr;
40(6):e69-e70.
PMID: 28385685
No abstract available.
8.
Renard E, Place J, Benbrahim N, Diouri O, Farret A
Rev Infirm
. 2017 Apr;
66(230):35-37.
PMID: 28366258
Almost 45 000 patients with type 1 diabetes are concerned in France by outpatient insulin pump therapy. The first systems of insulin pump therapy guided by glycaemia have evolved driven...
9.
Marchand L, Kawasaki-Ogita Y, Place J, Fayolle C, Lauton D, Boulet F, et al.
J Diabetes Sci Technol
. 2017 Mar;
11(5):924-929.
PMID: 28303725
Background: We investigated the long-term effects of continuous subcutaneous insulin infusion (CSII) on glucose control and microvascular complications in patients with type 1 diabetes (T1D). Methods: A total of 157...
10.
Renard E, Farret A, Kropff J, Bruttomesso D, Messori M, Place J, et al.
Diabetes Care
. 2016 May;
39(7):1151-60.
PMID: 27208331
Objective: After testing of a wearable artificial pancreas (AP) during evening and night (E/N-AP) under free-living conditions in patients with type 1 diabetes (T1D), we investigated AP during day and...